NDC 83634-655 – Cisatracurium Besylate
Cisatracurium Besylate 10 mg/mL · Injection, Solution · Intravenous
Product NDC83634-655
Product details
- Brand name
- Cisatracurium Besylate
- Generic name
- Cisatracurium besylate
- Labeler
- Avenacy, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA216539
- Marketed since
- August 15, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Cisatracurium Besylate 10 mg/mL
Uses, dosage, side effects and warnings for Cisatracurium Besylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83634-655-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-655-20) / 20 mL in 1 VIAL, SINGLE-DOSE (83634-655-41) | Aug 15, 2026 |
Other Cisatracurium Besylate products
- 0409-1098 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1103 Cisatracurium Besylate 10 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1208 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-712 Cisatracurium Besylate 10 mg/5mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-713 Cisatracurium Besylate 200 mg/20mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-714 Cisatracurium Besylate 20 mg/10mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 72485-513 Cisatracurium Besylate 200 mg/20mL · Injection · Armas Pharmaceuticals
- 31722-312 Cisatracurium Besylate 10 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-313 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-314 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 65145-137 Cisatracurium Besylate 10 mg/mL · Injection · Caplin Steriles Limited
- 65145-135 Cisatracurium Besylate 2 mg/mL · Injection · Caplin Steriles Limited